Wszystko, na czym Ci zależy, w jednym miejscu
Śledź feedy: blogi, wiadomości, RSS i nie tylko. Prosty sposób, by czytać i przyswajać wybrane treści.
Pobierz FeederFeed RSS: Onkologia
Najczęściej obserwowane przez użytkowników Feeder kanały RSS Onkologia, w tym Nature Medicine, Massachusetts Medical Society: New England Journal of Medicine: Table of Contents i ClinicalTrials.gov: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days. Skopiuj adres URL kanału lub obserwuj go bezpłatnie w Feeder.
Powiązane tematy
Feed RSS: Zdrowie Feed RSS: Badania kliniczne Feed RSS: Badania medyczne Feed RSS: Zdrowie psychiczne Feed RSS: Psychologia Feed RSS: Zdrowie publiczne Feed RSS: Farmacja
Zaproponuj zmianęNature Medicine
Original research articles published in Nature Medicine range from basic findings that have clear implications for disease pathogenesis and therapy to the earliest phases of human investigation. Aiming to keep Ph.D. and M.D. readers informed of a wide range of biomedical research findings, the journal publishes the latest advances in cancer biology, vascular biology, neuroscience, inflammatory disease, infectious disease and metabolic disorders, among other fields. Reviews, Perspectives and other commissioned content clarify and give context to these biomedical research advances, and the News section reports on the latest developments in drug research and development.
Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
Table of Contents for New England Journal of Medicine. List of articles from both the latest and ahead of print issues.
ClinicalTrials.gov: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days
Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]
Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]: Latest results from PubMed
ClinicalTrials.gov: Ovarian Cancer | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Ovarian Cancer | Last update posted in the last 14 days
Nature Reviews Cancer
Nature Reviews Cancer publishes a dynamic and accessible mix of Reviews, Perspectives, Progress and Highlight articles on the most important primary research papers. All Reviews and Perspectives are carefully commissioned, written by leaders in the field and subject to rigorous peer-review – so that readers receive independent, high-quality and authoritative articles in each issue. The journal’s broad scope captures the essence of modern multidisciplinary cancer research – integrating cancer biology with new approaches to treatment, diagnosis and prevention. Non-specialists will benefit from the glossary and highlighted references, busy scientists will appreciate the ‘At-a-glance’ summaries, and experts will value the insight provided by top names in their field. Nature Reviews Cancer is the premier teaching and reference resource in cancer and has become the ‘must read’ review journal of cancer researchers worldwide.
Nature Reviews Cancer - Issue - nature.com science feeds
Nature Reviews Cancer publishes a dynamic and accessible mix of Reviews, Perspectives, Progress and Highlight articles on the most important primary research papers. All Reviews and Perspectives are carefully commissioned, written by leaders in the field and subject to rigorous peer-review – so that readers receive independent, high-quality and authoritative articles in each issue. The journal’s broad scope captures the essence of modern multidisciplinary cancer research – integrating cancer biology with new approaches to treatment, diagnosis and prevention. Non-specialists will benefit from the glossary and highlighted references, busy scientists will appreciate the ‘At-a-glance’ summaries, and experts will value the insight provided by top names in their field. Nature Reviews Cancer is the premier teaching and reference resource in cancer and has become the ‘must read’ review journal of cancer researchers worldwide.
Kura Oncology, Inc. News Releases
ASCO: Journal of Clinical Oncology: Table of Contents
Table of Contents for Journal of Clinical Oncology. List of articles from both the latest and ahead of print issues.
Medical Xpress - latest medical and health news stories
Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.
Endpoints News
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Business Wire - News by Company: Verastem, Inc.
Business Wire - The global leader in news distribution
The New England Journal of Medicine: Search Results in Hematology/Oncology
The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Hematology/Oncology. NEJM (https://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.
mantle cell lymphoma
mantle cell lymphoma: Latest results from PubMed
Coherus Biosciences Inc. Events
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients.